Professor Mark R Baker.  Strategic context  Service organisation in England  The research agenda  Drivers for the review  Main findings  Options.

Slides:



Advertisements
Similar presentations
Redesigning hospital systems Nigel Edwards Policy Director, NHS Confederation, UK Hon. Visiting Professor LSHTM.
Advertisements

Cancer Research UK strategy and funding Simon Vincent.
Implementing NICE guidance
Understanding the NHS reforms Jo Webber, Deputy Policy Director 20 th March 2012.
Consultant in rehabilitation
UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Jonathan Valabhji National Clinical Director for Obesity and Diabetes The NHS in England in August 2013 The National Agenda for Diabetes.
Engaging with the NHS Commissioning Board and the impact of the changes in the wider LHE Simon Weldon, NHS Commissioning Board London Regional Team London.
Options for the Future of Payment by Results (PbR) – Consultation exercise Sebastian Habibi – May 2007.
Transforming Services Media briefing Northumberland, Tyne and Wear NHS Foundation Trust.
Local Education and Training Boards Adam C Wardle Managing Director, Yorkshire and the Humber Local Education and Training Board.
New Papworth Hospital Bidders’ Day 7 September 2010.
Monday 17 September (Materials presented to the Mayoral Team on 28 August 2012)
A Research Active Hospice
Shaping a blueprint for cancer Plymouth Cancer Summit Sean Duffy February 2015.
Welcome to the NIHR Peter Knight, Deputy Director Research Contracting, Information Intelligence and Stakeholder Engagement NIHR Trainees Meeting Leeds.
Clinical trials in Europe Emma Greenwood, Policy Manager Thursday 23 rd February.
Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June
Northern Trust Lymphoedema Stakeholder Event Elaine Stowe Lymphoedema Lead Northern Trust Feb 2010.
The BHRUT Clinical Strategy Presentation for stakeholders, patients and the public.
Creating partnerships for recovery Jo Roebuck Deputy Regional Manager London Region.
The National Cancer Intelligence Network An overview Professor David Forman Professor of Cancer Epidemiology, University of Leeds NCIN – Lead for Information.
Organisational Journey Challenges of Spreading self- management support Workshop 3 13 th May 2015.
Consultant Pharmacists
NIHR Delivering Better Health 26 November 2013, Leeds Dr David Cox Deputy Director – Research Finance & Programmes.
South West Specialised Commissioning Group Selena Blake - Programme Manager Teenage and Young Adults Cancer Services South West Specialised Commissioning.
AHSN Stakeholder Event Centre for Life, Newcastle Tuesday 23 rd June 2015 Patient Safety Collaboratives: the North East approach Tony Roberts, Interim.
Dr David Jackson Clinical Lead for Research YCRN Co-director WYCLRN Yorkshire Palliative Medicine Regional Learning Group April 2008 Clinical Research.
Healthcare plays an important though proportionately small role in preventing early deaths. Improving how we live our lives offers far greater.
∂ School of Medicine & Health. The Changing National Context Presented by David Hunter Professor of Health Policy and Management 13 th November 2012.
Upper GI Research and Clinical Trials Update Bridget Workman Research Manager NECRN N 21 ST November 2012.
NHS | Presentation to [XXXX Company] | [Type Date]1 Senates - the interface with SCNs and AHSNs Nigel Acheson Medical Director NHS England (South)
The Cancer Control Programme in England Lindsay Wilkinson Head of Cancer Policy Team – Department of Health (England)
Experimental Cancer Medicine – the future of cancer care Rosie Davies (LECMC RP based at RLUH) Janet Davies (LECMC RP based at CCO)
Northern England Strategic Clinical Network Conference 15 th May 2015 Vascular Update Professor Gerard Stansby Newcastle upon Tyne
Ms Rebecca Brown Deputy Director General, Department of Health
Developing a Referral Management Plan. Background Hospital referral rates in England have increased significantly over recent years, resulting in the.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
Organisational Journey Supporting self-management
NHS England New Structure and Industry Engagement Richard Stubbs Head of Commercial and International Innovation NHS England.
ENT, OMF and Head and Neck Cancer Services Review Mary Hutton 27 th January 2011.
World Class Commissioning and World Class Informatics, the quest for quality information Jan Sobieraj - Chief Executive, NHS Sheffield.
Presentation heading Presented by / Sub-heading Commissioning Explained Sarah Freeman Local Service Specialist – West Midlands Team.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Northern England Strategic Clinical Network Conference 15 th May 2015 Stroke Update Elizabeth Morris Network Delivery Team Manager.
Supporting Development of Organisational Knowledge Management Strategy NHS Librarians Meeting 3 rd June 2010.
Breast Radiotherapy Rehabilitation Injury Service A national multi-disciplinary service for consequences of breast radiotherapy Denise Moorhouse RGN Specialty.
Consumer Advocacy and Support Groups DELIVERING LOCAL SUPPORT IN A NATIONAL FRAMEWORK to future generations of hearing impaired Australians John Cook President.
The Implementation Plan for Rare Diseases in Scotland abcdefghijklmnopqrstuabcdefghijklmnopqrstu.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
London cancer workshop 9 th March Agenda TimeSession 2.00pmWelcome and objectives 2.10pmThe model of care 2.25pmProvider network development 2.45pmQuestion.
UK Clinical Sarcoma Research. Changes in UK Appointment of Cancer Tsar Use of NICE to evaluate care pathways and technology/drugs Minimum datasets established.
Neurosciences National Framework for Service Change Criteria Options Neurological Alliance Sub group 7 th December 2004 Agenda Item 4.1.
Anthony Kealy Commissioning Policy Team Policy & Strategy Directorate Developing Commissioning.
Key challenges facing the NHS Professor Chris Ham Chief Executive 21 September 2015.
Slide 1 UCLH Cancer Collaborative (part of the National Cancer Vanguard with RM Partners, and Greater Manchester Cancer)
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
Transforming Dementia Support and Services David Behan, Director General Social Care, Local Government and Care Partnerships Tuesday 6 th October.
Welcome to Southern Health Southern Health exists to improve the health, wellbeing and independence of the people we serve.
3T Programme 1:500 design 12 th March BSUH Strategic Vision Leading UK Teaching Hospital on two acute campuses, in partnership with BSMS, Deanery.
NHS Research & Development North West Dr Lynne Goodacre Assistant Director NHS Health Education North West.
Thames Valley Strategic Clinical Network TV Cancer SCN Head and Neck Cancer Workshop Bernadette Lavery Cancer Clinical Director 24 th February 2016.
New Economy Breakfast Seminar – 13 July What Has Changed?
Looking Ahead David Relph, Director. Working with others in our city and city region, Bristol Health Partners exists to support efforts to improve the.
Developing the role of Clinical Research Practitioners in the NHS:
Teaching Schools in the current educational landscape
Making MDTs better Steve Falk
Chemotherapy Services in England: Ensuring quality and safety
Our Vision / A look forward
28th November 2016 – First Meeting
Presentation transcript:

Professor Mark R Baker

 Strategic context  Service organisation in England  The research agenda  Drivers for the review  Main findings  Options and preferences  Politics and pragmatism  Interim improvements

 20 years of neglect  EUROCARE, 1993  Expert Advisory Group,  Improving Outcomes Guidance,  Cancer Peer Review  Creation of NICE, 1999  NHS Cancer Plan, 2000  National Radiotherapy Advisory Group, 2007  Cancer Reform Strategy, 2007

 Calman/Hine iteration 1995 ◦ Centres and Units  Improving Outcomes Guidance ◦ Centre teams and Unit teams  Peer review 2004 ◦ Specialist teams and Local teams  Centralised the complex and rare; localise everything else  Basic principles of team working, specialisation, centralisation required for specialisation

 1999 review of NHS R&D  Top priority (only one funded) was to establish an infrastructure in the NHS for the conduct of cancer clinical trials  NCRN created in 2001 ◦ Local networks built on service networks as rest of NHS was in chaos  NCRI – national partnership of (non-commercial) funders  Goal of improving research quality, speeding up and increasing recruitment, building research capacity and spin-off benefits for patient care

 No academic oncology in Liverpool (by far the largest centre without)  CRUK looking to accredit 15 cancer research centres in UK incl. Liverpool  Isolation of oncology centre seen as obstacle to developing academic oncology  Service is isolated and misplaced ◦ Over-centralised and self-indulgent ◦ Surgical fragmentation and oncology isolation make for messy pathways and lack of synergy

 Commitment to expand RT through use of satellite units  CRN has hit a glass ceiling  Perceived opportunity to invest in the short term (misplaced as it happens) by commissioners

 Service needs are more important than research needs in driving change  Physical isolation of oncology centre inhibits treatment development and ambition  Fragmentation of specialist services restricts team building and strength  Commitment to satellite radiotherapy provides the opportunity to think radically about location, synergy and building strength  Can’t do cancer without research and can’t do research without academic oncology

 Move the main inpatient base to Central Liverpool, teaching hospital campus  Align specialist oncology with specialist onco-surgery  Deliver radiotherapy on three sites  Devolve chemotherapy much more  Resistance of oncologists to supporting two inpatient units is an obstacle  Inadequate corporate infrastructure, paranoia and status of oncology centre is major block

 If major relocation scheme is not short-term: ◦ Proceed with satellite RT Units ◦ Retain opportunity to develop one (at Aintree) into a linked centre with IP beds ◦ Develop academic oncology at the RLH campus under university auspices – relationship with oncology centre to be determined  If financial opportunities improve: ◦ Have a scheme to centralise oncology at RLH ready to pounce